IBDEI080 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10517,1,3,0)
 ;;=3^HIV Positive
 ;;^UTILITY(U,$J,358.3,10517,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,10517,2)
 ;;=Asymptomatic HIV Status^303392
 ;;^UTILITY(U,$J,358.3,10518,0)
 ;;=921.0^^72^693^16
 ;;^UTILITY(U,$J,358.3,10518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10518,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,10518,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,10518,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,10519,0)
 ;;=379.91^^72^693^86
 ;;^UTILITY(U,$J,358.3,10519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10519,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,10519,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,10519,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,10520,0)
 ;;=V58.69^^72^693^44
 ;;^UTILITY(U,$J,358.3,10520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10520,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,10520,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,10520,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,10521,0)
 ;;=871.4^^72^693^54
 ;;^UTILITY(U,$J,358.3,10521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10521,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,10521,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,10521,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,10522,0)
 ;;=242.90^^72^693^107
 ;;^UTILITY(U,$J,358.3,10522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10522,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,10522,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,10522,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,10523,0)
 ;;=135.^^72^693^100
 ;;^UTILITY(U,$J,358.3,10523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10523,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,10523,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,10523,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,10524,0)
 ;;=446.5^^72^693^106
 ;;^UTILITY(U,$J,358.3,10524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10524,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,10524,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,10524,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,10525,0)
 ;;=401.9^^72^693^49
 ;;^UTILITY(U,$J,358.3,10525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10525,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,10525,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,10525,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,10526,0)
 ;;=V72.0^^72^693^32
 ;;^UTILITY(U,$J,358.3,10526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10526,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,10526,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,10526,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,10527,0)
 ;;=V41.0^^72^693^90
 ;;^UTILITY(U,$J,358.3,10527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10527,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,10527,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,10527,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,10528,0)
 ;;=998.59^^72^693^88
 ;;^UTILITY(U,$J,358.3,10528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10528,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,10528,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,10528,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,10529,0)
 ;;=042.^^72^693^1
 ;;^UTILITY(U,$J,358.3,10529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10529,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,10529,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,10529,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,10530,0)
 ;;=053.29^^72^693^43
 ;;^UTILITY(U,$J,358.3,10530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10530,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,10530,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,10530,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,10531,0)
 ;;=054.40^^72^693^42
 ;;^UTILITY(U,$J,358.3,10531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10531,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,10531,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,10531,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,10532,0)
 ;;=190.1^^72^693^82
 ;;^UTILITY(U,$J,358.3,10532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10532,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,10532,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,10532,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,10533,0)
 ;;=190.2^^72^693^50
 ;;^UTILITY(U,$J,358.3,10533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10533,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,10533,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,10533,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,10534,0)
 ;;=190.7^^72^693^52
 ;;^UTILITY(U,$J,358.3,10534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10534,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,10534,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,10534,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,10535,0)
 ;;=202.81^^72^693^61
 ;;^UTILITY(U,$J,358.3,10535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10535,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,10535,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,10535,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,10536,0)
 ;;=215.9^^72^693^84
 ;;^UTILITY(U,$J,358.3,10536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10536,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,10536,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,10536,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,10537,0)
 ;;=224.2^^72^693^51
 ;;^UTILITY(U,$J,358.3,10537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10537,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,10537,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,10537,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,10538,0)
 ;;=224.5^^72^693^95
 ;;^UTILITY(U,$J,358.3,10538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10538,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,10538,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,10538,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,10539,0)
 ;;=224.7^^72^693^28
 ;;^UTILITY(U,$J,358.3,10539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10539,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,10539,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,10539,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,10540,0)
 ;;=237.70^^72^693^66
 ;;^UTILITY(U,$J,358.3,10540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10540,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,10540,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,10540,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,10541,0)
 ;;=239.6^^72^693^65
 ;;^UTILITY(U,$J,358.3,10541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10541,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,10541,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,10541,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,10542,0)
 ;;=239.81^^72^693^96
 ;;^UTILITY(U,$J,358.3,10542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10542,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,10542,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,10542,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,10543,0)
 ;;=272.0^^72^693^48
 ;;^UTILITY(U,$J,358.3,10543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10543,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,10543,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,10543,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,10544,0)
 ;;=340.^^72^693^63
 ;;^UTILITY(U,$J,358.3,10544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10544,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,10544,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,10544,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,10545,0)
 ;;=345.90^^72^693^29
 ;;^UTILITY(U,$J,358.3,10545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10545,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,10545,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,10545,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,10546,0)
 ;;=368.02^^72^693^23
 ;;^UTILITY(U,$J,358.3,10546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10546,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,10546,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,10546,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,10547,0)
 ;;=368.11^^72^693^102
 ;;^UTILITY(U,$J,358.3,10547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10547,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,10547,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,10547,2)
 ;;=^268831
 ;;^UTILITY(U,$J,358.3,10548,0)
 ;;=368.59^^72^693^11
 ;;^UTILITY(U,$J,358.3,10548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10548,1,3,0)
 ;;=3^Color Blindness
 ;;^UTILITY(U,$J,358.3,10548,1,4,0)
 ;;=4^368.59
 ;;^UTILITY(U,$J,358.3,10548,2)
 ;;=^87408
 ;;^UTILITY(U,$J,358.3,10549,0)
 ;;=368.60^^72^693^67
 ;;^UTILITY(U,$J,358.3,10549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10549,1,3,0)
 ;;=3^Night Blindness
 ;;^UTILITY(U,$J,358.3,10549,1,4,0)
 ;;=4^368.60
 ;;^UTILITY(U,$J,358.3,10549,2)
 ;;=^83350
 ;;^UTILITY(U,$J,358.3,10550,0)
 ;;=368.9^^72^693^113
 ;;^UTILITY(U,$J,358.3,10550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10550,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,10550,1,4,0)
 ;;=4^368.9
 ;;^UTILITY(U,$J,358.3,10550,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,10551,0)
 ;;=369.00^^72^693^108
 ;;^UTILITY(U,$J,358.3,10551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10551,1,3,0)
 ;;=3^Total Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,10551,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,10551,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,10552,0)
 ;;=369.01^^72^693^109
 ;;^UTILITY(U,$J,358.3,10552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10552,1,3,0)
 ;;=3^Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,10552,1,4,0)
 ;;=4^369.01
 ;;^UTILITY(U,$J,358.3,10552,2)
 ;;=^268861
 ;;^UTILITY(U,$J,358.3,10553,0)
 ;;=369.02^^72^693^75
 ;;^UTILITY(U,$J,358.3,10553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10553,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye-NOS
 ;;^UTILITY(U,$J,358.3,10553,1,4,0)
 ;;=4^369.02
 ;;^UTILITY(U,$J,358.3,10553,2)
 ;;=^268862
 ;;^UTILITY(U,$J,358.3,10554,0)
 ;;=369.03^^72^693^74
 ;;^UTILITY(U,$J,358.3,10554,1,0)
 ;;=^358.31IA^4^2
